Clinical Study

Transcription of the Tumor Suppressor Genes p53 and RB in Lymphocytes from Patients with Chronic Kidney Disease: Evidence of Molecular Senescence?

Table 2

Expression of p53 and RB in cultured and noncultured cells.

Pairs analyzed
p53RB
Difference in expressionStatistical analysis
value/standard error range
Difference
factor
Difference in expressionStatistical analysis
value/standard error range
Difference
factor

A before culture—A plain culture 0.000/0.013–0.5410.131 0.001/0.004–0.5530.083
A before culture—A culture with LPS 0.000/0.026–0.6640.190 0.000/0.003–0.5770.080
A before culture—A culture with CRP 0.000/0.008–0.1970.048 0.000/0.014–0.2650.062
A before culture—A culture with LPS-LXA4 0.000/0.033–0.9030.226 0.001/0.053–0.8740.235
A before culture—B before culture 0.056 0.260
A before culture—C before culture 0.337 0.105
B before culture—B plain culture 0.001/0.048–0.2490.176 0.001/0.052–0.6220.222
B before culture—B culture with LPS 0.000/0.081–0.4920.202 0.000/0.113–0.6140.280
B before culture—B culture with CRP 0.000/0.017–0.2360.075 0.000/0.030–0.4080.097
B before culture—B culture with LPS-LXA4 0.000/0.118–0.8070.333 0.002/0.157–1.2670.460
C before culture—C plain culture 0.071 0.239
C before culture—C culture with LPS 0.024/0.033–1.6080.257 0.318
C before culture—C culture with CRP 0.000/0.021–0.2500.071 0.000/0.060–0.5150.180
C before culture—C culture with LPS-LXA4 0.001/0.054–0.5950.247 0.050/0.188–1.7530.500

A: healthy controls; B: CKD patients; C: Dialysis patients; these results are derived from REST software which analyzed the Ct values calculated from the real time PCR experiments.